Association for the Advancement of Blood & Biotherapies

Dr. Peter Marks MD, PhD

Director, Center for Biologics Evaluation and Research, FDA

Appearances

AM20-33: COVID-19 Convalescent Plasma (CCP) -- The Regulatory Landscape
21EL-601 On-Demand Hot Topic Discussion: COVID-19 Vaccines, PrEP, MSM – What You Need to Know Heading Into 2021

Item	Price	Remove